Coronavirus Update - 14th October 2020

Despite the recent rises in Covid-19 cases throughout the UK and Europe, Arcinova remains open for business at full capacity as we have done throughout this pandemic. As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

Webinars from the Arcinova team

Pharmaceutical companies are currently investing in the development of continuous chemical processes to reduce costs and accelerate the delivery of new molecules to the market. While the spotlight usually falls on the giant multi-nationals that are sinking millions into new high-tech continuous manufacturing facilities, there are a lot of small CROs quietly implementing their own cost-effective solutions.

In this webinar we discuss the implementatation of continuous manufacturing technologies for the first time at Arcinova and demonstrate how continuous flow reactor technologies can provide robust solutions which can deliver distinct advantages over more traditional batch approaches.

PLEASE NOTE: During the introduction slide we were experiencing sound issues however, this rectifies itself after this first slide. Please DO NOT exit the webinar or turn up the volume as this is a fault with the recording.